| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/23/2011 | WO2011073172A1 Ethynyl derivatives |
| 06/23/2011 | WO2011073165A1 New phenylhydrazone derivatives and their use as pharmaceuticals |
| 06/23/2011 | WO2011073160A1 Pyrrolidine derivatives as nk - 3 receptor antagonists |
| 06/23/2011 | WO2011073155A1 Novel antagonists for ccr2 and uses thereof |
| 06/23/2011 | WO2011073154A1 New ccr2 receptor antagonists and uses thereof |
| 06/23/2011 | WO2011073119A1 Mk2 inhibitors |
| 06/23/2011 | WO2011073118A1 Novel solvates of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate |
| 06/23/2011 | WO2011073117A1 Azaindole glucokinase activators |
| 06/23/2011 | WO2011073114A1 Heterocyclic antiviral compounds |
| 06/23/2011 | WO2011073112A2 Mannose derivatives as antagonists of bacterial adhesion |
| 06/23/2011 | WO2011073092A1 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment |
| 06/23/2011 | WO2011073091A1 3-(indolyl)-or 3-(azaindolyl)- 4-arylmaleimide derivatives for use in the treatment of colon and gastric adenocarzinoma |
| 06/23/2011 | WO2011073002A1 Antibiotic microparticles for inhalation |
| 06/23/2011 | WO2011072861A1 Suppository comprising pantoprazole |
| 06/23/2011 | WO2011072839A1 Orodispersible tablet, containing dapoxetine |
| 06/23/2011 | WO2011072791A1 Sphingosine kinase inhibitors |
| 06/23/2011 | WO2011072779A1 Thiazole derivatives for treating diseases such as cancer |
| 06/23/2011 | WO2011072728A1 Composition in form of a gel for the virucidal disinfection of mammalian skin |
| 06/23/2011 | WO2011072697A1 Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors |
| 06/23/2011 | WO2011072696A1 2-arylimidazole derivatives as pde10a enzyme inhibitors |
| 06/23/2011 | WO2011072695A1 Phenylimidazole derivatives comprising an ethynylene linker as pde10a enzyme inhibitors |
| 06/23/2011 | WO2011072694A1 Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors |
| 06/23/2011 | WO2011072691A1 Pyridone derivatives as nk3 antagonists |
| 06/23/2011 | WO2011072623A1 Benzomacrolides with pancreatic lipase inhibition, methods of preparation and uses thereof |
| 06/23/2011 | WO2011072619A1 Traditional chinese drug comprising danshen extracts and sanqi extracts and use thereof |
| 06/23/2011 | WO2011072510A1 Passive solid tumor targeting anticancer prodrug and preparation method thereof |
| 06/23/2011 | WO2011072509A1 Progesterone formulation composition and preparation method thereof |
| 06/23/2011 | WO2011072496A1 Epothilone compounds, preparation method and use thereof |
| 06/23/2011 | WO2011072488A1 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists |
| 06/23/2011 | WO2011072474A1 Double-layer osmotic pump controlled release tablet of bicyclol and preparation method thereof |
| 06/23/2011 | WO2011072398A1 Local delivery of drugs from self assembled coatings |
| 06/23/2011 | WO2011072394A1 METHOD OF TREATING SCARS AND ß-CATENIN-MEDIATED DISORDERS USING NEFOPAM COMPOUNDS |
| 06/23/2011 | WO2011072390A1 Compositions and methods related to mirna in diabetic conditions |
| 06/23/2011 | WO2011072383A1 Processes for the purification of lubiprostone |
| 06/23/2011 | WO2011072370A1 Hcv combination therapy |
| 06/23/2011 | WO2011072336A1 Antiviral agents |
| 06/23/2011 | WO2011072320A1 Effervescent l-carnitine-based composition |
| 06/23/2011 | WO2011053172A3 Drug for treating hiv/aids infections and the loss of sexual desire, method for preparing same and use thereof. |
| 06/23/2011 | WO2011053139A3 Aqueous composition for topical application, method of preparation, uses and device |
| 06/23/2011 | WO2011051960A3 Process for producing rapamycin derivatives |
| 06/23/2011 | WO2011051490A3 Heterocyclic derivatives |
| 06/23/2011 | WO2011050994A3 Closthioamides |
| 06/23/2011 | WO2011041599A3 6-methylvitamin d3 analogs and their uses |
| 06/23/2011 | WO2011030166A9 The use of lipid emulsions for binding hepatitis c virus |
| 06/23/2011 | WO2011028334A3 Synthesis and isolation of dendrimer systems |
| 06/23/2011 | WO2011027365A3 Ophthalmic compositions containing dorzolamide, timolol and brimonidine |
| 06/23/2011 | WO2011027344A3 Combination of vitamin e and beta-glycosphingolipids in compositions and methods for preventing and treating hepatic disorders |
| 06/23/2011 | WO2011022539A9 Methods for administration of colchicine with grapefruit juice |
| 06/23/2011 | WO2011022508A3 Substituted benzoazepines as toll-like receptor modulators |
| 06/23/2011 | WO2011022393A3 Phosphatidylcholine transfer protein inhibitors |
| 06/23/2011 | WO2011022028A3 Small molecule antagonists of phosphatidylinositol-3, 4, 5-triphosphate (pip3) and uses thereof |
| 06/23/2011 | WO2011020090A3 Compositions and methods for treating cancer |
| 06/23/2011 | WO2011019400A9 Enhancement of cellular transplantation using small molecule modulators hepatocyte growth factor (scatter factor) activity |
| 06/23/2011 | WO2011017554A3 Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
| 06/23/2011 | WO2011017456A3 Localized delivery of nanoparticles for therapeutic and diagnostic applications |
| 06/23/2011 | WO2011017404A3 Retroelements and mental disorders and methods of measuring l1 retrotransposition |
| 06/23/2011 | WO2011014588A3 Dermal formulations of dp2 receptor antagonists |
| 06/23/2011 | WO2011014520A3 Compounds and compositions as modulators of gpr119 activity |
| 06/23/2011 | WO2011012400A3 Nitric oxide releasing naproxen |
| 06/23/2011 | WO2011011700A3 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
| 06/23/2011 | WO2011004391A3 An improved process for the preparation of eletriptan and its salt thereof |
| 06/23/2011 | WO2011001165A3 Anti-acne formulations containing a dialkyl sulphosuccinate and salicylic acid |
| 06/23/2011 | WO2010148050A3 Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene |
| 06/23/2011 | WO2010132765A3 Antibacterial aminoglycoside analogs |
| 06/23/2011 | WO2010089775A3 Improved drug dosage form for controlled delivery of one or more pharmaceutically active agent |
| 06/23/2011 | WO2010066832A8 Triple substituted phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases or conditions, or cancer |
| 06/23/2011 | WO2009124300A3 Solid state forms of a pharmaceutical |
| 06/23/2011 | US20110154530 Plants with Increased Yield by Increasing or Generating One or More Activities in a Plant or a Part Thereof |
| 06/23/2011 | US20110154517 Disorders of vasoregulation and methods of diagnosing them |
| 06/23/2011 | US20110153302 Identification of drug effects on signaling pathways using integer linear programming |
| 06/23/2011 | US20110153007 Taxane Coatings for Implantable Medical Devices |
| 06/23/2011 | US20110152797 Prostaglandins and analogues as agents for lowering intraocular pressure |
| 06/23/2011 | US20110152766 Implant with coating |
| 06/23/2011 | US20110152746 Methods for generating new hair follicles, treating baldness, and hair removal |
| 06/23/2011 | US20110152509 Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them |
| 06/23/2011 | US20110152383 Compositions comprising benzyl alcohol derivatives and further antimicrobial active compounds |
| 06/23/2011 | US20110152382 Composition of molecular elements for phosphorylase kinase inhibition |
| 06/23/2011 | US20110152381 3-keto-n-propargyl-1-aminoindan |
| 06/23/2011 | US20110152380 Paediatric Compositions For Treating Multiple Sclerosis |
| 06/23/2011 | US20110152379 Composition for control of aging and/or extension of life, containing dapsone as active ingredient |
| 06/23/2011 | US20110152377 External preparation comprising fatty acid salt or benzoic acid salt of basic pharmacologically active component, and method for production thereof |
| 06/23/2011 | US20110152376 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof |
| 06/23/2011 | US20110152375 Method of reducing the methane gas level and of increasing the total gas yield in animal feed |
| 06/23/2011 | US20110152374 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease |
| 06/23/2011 | US20110152373 Hair growth promoting agent containing 15,15-difluoroprostaglandin f2alpha derivative as active ingredient |
| 06/23/2011 | US20110152372 Anhydrous petroleum jelly/elastomer-free depigmenting compositions comprising a solubilized phenolic compound and a retinoid |
| 06/23/2011 | US20110152371 Antioxidant extract from fruit skins |
| 06/23/2011 | US20110152367 Process for the preparation of fesoterodine with low impurities content |
| 06/23/2011 | US20110152366 N-alkylcarbonyl-amino acid ester compounds and their use for skin irritation, itch, and pain |
| 06/23/2011 | US20110152364 Compositions for repelling fluid and uses thereof |
| 06/23/2011 | US20110152363 Organically chelated mineral compositions and methods thereof |
| 06/23/2011 | US20110152362 Methods of treating epileptogenesis and epilepsy |
| 06/23/2011 | US20110152361 Novel epigallocatechin gallate tetramer and vascular endothelial function improving agent containing the same |
| 06/23/2011 | US20110152360 Liquid pharmaceutical formulations of docetaxel |
| 06/23/2011 | US20110152359 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising threreof |
| 06/23/2011 | US20110152358 Compositions and Methods for Diagnosis and Treatment of Pancreatic Ductal Cancer |
| 06/23/2011 | US20110152357 Micro-RNA-Based Compositions and Methods for the Diagnosis, Prognosis and Treatment of Multiple Myeloma |
| 06/23/2011 | US20110152356 NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION |
| 06/23/2011 | US20110152355 Method for predicting and detecting tumor metastasis |
| 06/23/2011 | US20110152354 Bispecific Oligonucleotide for the Treatment of CNS Malignancies |